Home › Funds › Hood River Capital Management LLC › BBIO

Hood River Capital Management LLC position in BBIO

BRIDGEBIO PHARMA INC · Health Care

Hood River Capital Management LLC reported holding 1,347,535 shares of BBIO (BRIDGEBIO PHARMA INC) in its Q2 2026 13F filing — a position valued at US$100.4M, representing 0.73% of its reported portfolio and ranking #42 among its reported holdings. Hood River Capital Management LLC has disclosed BBIO holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)1.35M sh
Reported value held$100.36M
Portfolio Weight0.73%
First reportedQ3 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Hood River Capital Management LLC's BBIO position evolved

Hood River Capital Management LLC first disclosed a stake in BBIO in Q3 2025 at 1,243,545 shares (US$64.6M). The position peaked in Q2 2026 at 1,347,535 shares, worth US$100.4M. Across 4 filings, Hood River Capital Management LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,347,535 shares valued at US$100.4M — an increase of 82,455 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2025 1.24M $64.59M New
Q4 2025 1.26M $96.01M Add
Q1 2026 1.27M $93.94M Add
Q2 2026 1.35M $100.36M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BBIO and 13F data

BBIO (BRIDGEBIO PHARMA INC) is a Health Care company. 47 other funds we track also report a position in BBIO — the largest reported positions include Jupiter Topco LLC (US$1.05B), Janus Henderson Group (US$978.6M), Farallon Capital Management (US$800.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BBIO

All BBIO fund holders →

FAQ

How long has Hood River Capital Management LLC held BBIO?

Hood River Capital Management LLC has disclosed BBIO holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Hood River Capital Management LLC's current position in BBIO?

As of Q2 2026, Hood River Capital Management LLC holds 1.35M shares of BBIO (BRIDGEBIO PHARMA INC), valued at $100.36M, representing 0.73% of its reported portfolio and ranking #42.

Has Hood River Capital Management LLC been buying or selling BBIO?

In the latest 13F filing (Q2 2026), Hood River Capital Management LLC increased its position in BBIO. The position peaked in Q2 2026 at 1.35M shares.

Which other funds hold BBIO?

Other major institutional holders of BBIO include Jupiter Topco LLC, Janus Henderson Group, Farallon Capital Management, among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.